At Nasseri Clinic of Arthritic and Rheumatic Diseases, Dr
These medications work by directly activating the GLP-1 receptor, amplifying the hormones effects
A 2022 trial showed patients regained two-thirds of their weight loss within one year of stopping semaglutide Other Key Considerations Pre-op guidance: Most patients should continue taking their glucagon-like peptide-1 (GLP-1) receptor agonists before elective surgery
However, increasing competition, generic liraglutide availability, upcoming semaglutide patent expiration (2026), and Novo Nordisks announced list price cuts are all expected to improve affordability over the coming years
Users stopping niacinamide typically experience very gradual benefit decline over 1-3 months without dramatic reversal, maintaining 40-60% of improvements long-term if treatment lasted 6+ months, and tolerating breaks or cycling without rebound effects or significant regression concerns
That keeps hypoglycemia risk low and makes experiments easier to control